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Objective: To determine the incidence and characteristics of
inappropriate shock therapy in a series of consecutive patients
with ICD. Introduction: Implantable cardioverter defibrillators
have demonstrated to reduce mortality in patients with
ventricular arrhythmias. However, ICD therapy is associated
with the drawback of inappropriate shock therapy, which may
be associated with serious complications such as pro-
arrhythmia, disturbances in quality of life, and an increase in
mortality. Methods: All patients followed in our ICD clinic
with inappropriate shock episodes underwent review of the
stored electrograms from the devices. All devices were 3rd
generation ICDs with activated SVT discrimination algo-
rithms (sudden onset, rate stability, QRS width and morphol-
ogy, and analysis of atrial electrograms in dual chamber
devices). Results: During 36 months mean follow-up, 24 of
290 patients (8%) received a total of 32 episodes of
inappropriate shock therapy (with a total of 98 shocks, mean
of 3.06 shocks per episode). Seventy-nine percent of patients
had a single-chamber device implanted and in 83% of cases
devices were implanted for secondary prevention. In 23 of 32
episodes, inappropriate shocks (72% of total chocks) were
caused by supraventricular arrhythmias (atrial fibrillation with
fast ventricular rate, sinus tachycardia or atrial flutter). The
remaining 9 episodes (28% of shocks) were caused by Twave
oversensing, myopotential oversensing or artifact sensing.
Conclusión: Despite routine use of SVT discrimination
algorithms, 8% of ICD patients continue to receive inappro-
priate ICD shocks during follow-up. Recognition of the
mechanisms causing inappropriate shock therapy is crucial
to optimise ICD programming and to avoid inappropriate
shocks. The electrode, which is responsible of artifact sensing,
continues to be the fragile component of the system.
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It has been documented the impact of therapy with
implantable cardioverter-defibrillator (ICD) and cardiac
resynchronization therapy (CRT) on quality of life (QOL)
in patients (P) with severe congestive heart failure (CHF).
However, the sustained effect of these treatment modalities
in the different dimensions that constitutes QOL remains
controversial. Objective: To evaluate the impact of CRT and
ICD in QOL of P with CHF refractory to optimal
pharmacological therapy in consecutive sequential analysis
in the first 6 months after implantation of these devices.
Population and Methods: 96P (52P underwent implantation
of CRT system combined with ICD (CRT-D) and 44P
systems with ICD) followed in the primary prevention of
sudden death, without detection of ventricular tachyarrhyth-
mias during the first 6 months post- implant. P were assessed
at admission, immediately before the intervention, and in
outpatient clinic within 6 months. We considered the NYHA
functional class, ejection fraction (LVEF) and the Kansas
City Cardiomiophathy QOL Questionnaire (KCCQ). Results:
In the CRT-D group, age was 64±2 (37–78) years with 35P
males and 17P females, LVEF 25±6 and 94% in NYHA
class III. At 3 and 6 months CRT was associated with
improved NYHA, LVEF and QOL in the various fields and
sums assessed (ρ<0.05). In the ICD group, age was 61±13
(25–83) years with 38 P males and 6 P females, LVEF 26±5
and 84% in NYHA class II. At 3 and 6 months ICD was
associated with improved NYHA and QOL only in activity
of daily living field, perception of life satisfaction and overall
quality of life (ρ<0.05). Conclusion: In a selected population
with severe CHF, CRT was associated with a sustained
benefit held in all domains of QOL, functional class and left
ventricular function. In the group with ICD, this sustained
effect was restricted to functional class, the physical
dimension of QOL and perception of life satisfaction.
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